Ambica International Corporation

What Ambica International Corporation does

Ambica International Corporation is a Philippines-based pharmaceutical distribution company founded in 2003 and headquartered in Merville Subdivision. Operating for 20 years under the Dr. Ambica brand, the company distributes pharmaceutical products across the Philippine archipelago through an established direct distribution network that reaches pharmacies, healthcare providers, and medical facilities throughout the country. Its core value proposition centers on four pillars: accessibility (geographic reach into remote and underserved areas), availability (robust supply chain management with contingency planning), affordability (products spanning multiple income brackets, including subsidized medicines for the underprivileged), and advocacy (health literacy programs and support for public health initiatives). The company maintains strategic partnerships with local health organizations, NGOs, and government agencies to deliver subsidized medicines and support vaccination drives and disease awareness campaigns.

The company's go-to-market is built on direct distribution across the Philippine archipelago, augmented by partnerships with institutional stakeholders to extend reach into underserved populations. Revenue is generated through pharmaceutical product sales, with pricing handled via quote-based contracts negotiated per customer or segment rather than publicly disclosed pricing. The customer base spans the general Filipino population, economically disadvantaged and remote communities, and chronic condition patients requiring continuity of medication. Marketing channels include a Health Tips content blog, Facebook and LinkedIn for brand engagement, and community advocacy initiatives. The headcount of 11-50 employees and the absence of disclosed funding rounds, acquisitions, or parent company structure indicate Ambica is an independent, privately held mid-sized distributor.

Operationally, the company emphasizes regulatory compliance and product safety in line with pharmaceutical industry standards, though no specific certifications or compliance credentials are disclosed. There is no evidence of proprietary technology, AI/ML capabilities, or digital platform infrastructure beyond a standard corporate website and social media presence. Growth signals are limited: the company has not expanded geographically beyond the Philippines, has not pursued M&A, and has not disclosed revenue or headcount trajectories. The business model is fundamentally traditional distribution, with defensibility resting on its archipelago-wide distribution network, two decades of brand equity, and institutional partnerships rather than on technology differentiation.

Name

Ambica International Corporation

Legal name

Ambica International Corporation

Website

https://ambicapharmaceuticals.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

Ambica International Corporation is a Philippines-based pharmaceutical distributor founded in 2003, operating for 20 years under the Dr. Ambica brand. It distributes medicines across the Philippine archipelago through direct channels and partnerships with NGOs and government agencies serving general and underserved populations.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Medical and Diagnostic Laboratories (6215)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

OTC & Consumer Health Distributors (HLAIAJAC)

Keywords

• Pharmaceutical distribution
• Medicine supply
• Healthcare products
• Pharmaceutical wholesale
• Drug distribution

Headquarters

HQ city

Merville Subdivision

HQ country

Philippines

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Ambica generates revenue through the sale of pharmaceutical products and medicines across the Philippines. The company offers a range of products catering to different income brackets, including subsidized medicines for underprivileged populations. Revenue is derived from product distribution through their established supply chain network.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Ambica International Corporation is a pharmaceutical distribution company that sources, distributes, and markets medicines and healthcare products across the Philippine archipelago under the Dr. Ambica brand. It operates a direct distribution network reaching healthcare providers, pharmacies, and medical facilities, and partners with government agencies, NGOs, and local health organizations to deliver subsidized medicines to underserved and underprivileged populations.

Product overview

Ambica International Corporation is a pharmaceutical distribution company operating in the Philippines. The company offers a portfolio of healthcare products centered around the Dr. Ambica brand, providing superior medicines and practical healthcare solutions. The company operates through a network of distribution channels across the Philippine archipelago, working with local health organizations and NGOs to provide access to products.

Differentiator

Problem solved

Functional benefit

Products and services

• Dr. Ambica Pharmaceutical Product Line

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core.

• Local Health OrganizationscoreStrategic or Co-development PartnerAmbica works closely with local health organizations to provide access to pharmaceutical products in underserved areas. These partnerships support the company's mission of ensuring healthcare accessibility regardless of geography or economic status.
• NGOscoreStrategic or Co-development PartnerAmbica collaborates with non-governmental organizations to provide subsidized medicines to underprivileged populations and support public health initiatives including vaccination drives and disease awareness campaigns.
• Government AgenciescoreStrategic or Co-development PartnerAmbica works with government agencies to provide subsidized medicines to the underprivileged, supporting national healthcare access initiatives and public health programs.

Scale indicators2 records

Recent moves5 records

Expansion highlights3 records

Direct peers

• RiteMED Philippines: A Philippine generics-focused pharmaceutical company distributing affordable medicines nationwide. Comparable to Ambica on affordability-focused distribution to mass-market and underserved Filipino consumers.
• Metro Drug (MDI): A major Philippine pharmaceutical distribution company supplying medicines to thousands of drugstores and institutions nationwide. Directly comparable to Ambica as a Filipino pharma wholesaler/distributor with broad product portfolios and nationwide reach.
• Zuellig Pharma: One of the largest pharmaceutical distributors in the Philippines and broader Southeast Asia, providing distribution, warehousing, and commercial services. Directly comparable to Ambica as both are pharma distribution specialists serving the Philippine market with manufacturer-to-pharmacy logistics.
• MedEthix: Philippine pharmaceutical distribution company serving drugstores, hospitals, and institutions. Directly comparable to Ambica as a domestic pharma wholesaler focused on broad product distribution within the Philippine market.

Broad incumbents

• AstraZeneca Philippines: Multinational pharmaceutical company with prescription and consumer health operations in the Philippines. Comparable to Ambica as a pharmaceutical supplier active in the Filipino healthcare market through distribution partnerships.
• Novartis Philippines: Multinational pharmaceutical manufacturer distributing innovative medicines and generics in the Philippines through local distribution channels. Comparable to Ambica as a pharma manufacturer whose products ultimately flow to Filipino patients via distributors like Ambica.
• GlaxoSmithKline Philippines: Multinational pharmaceutical manufacturer with established distribution in the Philippines for vaccines, consumer health, and prescription products. Comparable to Ambica as part of the pharmaceutical supply ecosystem serving Filipino healthcare providers.
• Sanofi Philippines: Multinational pharmaceutical company distributing prescription medicines, vaccines, and consumer health products in the Philippines. Comparable to Ambica as a pharma brand distributor leveraging local partnerships to reach Filipino patients.
• Unilab: The largest Philippine-owned pharmaceutical company with manufacturing, distribution, and consumer health operations across the country. Comparable to Ambica as a healthcare access champion in the Philippines, though Unilab operates as a manufacturer-distributor with much broader scale.
• Pfizer Philippines: Multinational pharmaceutical manufacturer with significant distribution operations in the Philippines. Comparable to Ambica as a supplier of pharmaceutical products to Filipino patients, though Pfizer is a manufacturer with its own branded portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/ambicainternationalcorp
• LinkedInlinkedin.com/company/ambica-international-corporation

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ambica International Corporation